This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Compared to Estimates, Ashland (ASH) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Ashland (ASH) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Ashland (ASH) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of -9.57% and -1.15%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Element Solutions (ESI) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Element Solutions (ESI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Ashland (ASH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ashland Advances Strategic $60M Manufacturing Network Optimization
by Zacks Equity Research
ASH is closing two New Jersey sites as part of a $60M plan to boost efficiency, cut costs and scale key tech production.
Are Options Traders Betting on a Big Move in Ashland Stock?
by Zacks Equity Research
Investors need to pay close attention to ASH stock based on the movements in the options market lately.
Why Is Ashland (ASH) Up 3.9% Since Last Earnings Report?
by Zacks Equity Research
Ashland (ASH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ashland's Q2 Earnings and Revenues Miss Estimates, Down Y/Y
by Zacks Equity Research
ASH's fiscal second-quarter sales are adversely impacted by the portfolio optimization actions.
Ashland (ASH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Ashland (ASH) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Ashland (ASH) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of -10% and 5.86%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Quaker Chemical (KWR) Q1 Earnings Expected to Decline
by Zacks Equity Research
Quaker Chemical (KWR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Blachem (BCPC) Lags Q1 Earnings Estimates
by Zacks Equity Research
Blachem (BCPC) delivered earnings and revenue surprises of -2.40% and 2.38%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Ashland (ASH) Q2 Earnings Expected to Decline
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Daqo (DQ) Soars 6.1%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Daqo (DQ) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Ashland Wraps Up Expansion of Pharmaceutical Plant in Brazil
by Zacks Equity Research
ASH is investing in modernizing equipment for microbial protection in personal care applications at its Technical Center in Sao Paulo.
Ashland Wraps Up Divestment of Avoca Business to Mane
by Zacks Equity Research
ASH closes the sales of its Avoca business, the last entity remaining from the Pharmachem acquisition.
Are Options Traders Betting on a Big Move in Ashland (ASH) Stock?
by Zacks Equity Research
Investors need to pay close attention to Ashland (ASH) stock based on the movements in the options market lately.
Ashland (ASH) Down 2.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ashland (ASH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ashland's Earnings Outpace Estimates, Revenues Miss in Q1
by Zacks Equity Research
Organic sales volume growth in ASH's Personal Care, Specialty Additives and Intermediates segments largely offset lower volumes in Life Sciences in Q1.
New Strong Sell Stocks for January 29th
by Zacks Equity Research
ARCAY, ASH and DNKEY have been added to the Zacks Rank #5 (Strong Sell) List on January 29, 2024.
Here's What Key Metrics Tell Us About Ashland (ASH) Q1 Earnings
by Zacks Equity Research
Although the revenue and EPS for Ashland (ASH) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ashland (ASH) Surpasses Q1 Earnings Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of 40% and 6.52%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
PPG Industries (PPG) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
PPG Industries (PPG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Stay Ahead of the Game With Ashland (ASH) Q1 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Ashland (ASH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Analysts Estimate Ashland (ASH) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Ashland (ASH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.